Table 1.
Frequencies of the explanatory variable considered in the study (n = 1.701).
| Explanatory Variable | Count (%) |
|---|---|
| Diabetes mellitus | 212 (12.46%) |
| Osteoporosis | 101 (5.94%) |
| Anemia | 85 (5.00%) |
| Coagulopathies | 24 (1.41%) |
| Hypertension | 576 (33.86%) |
| Heart failure | 27 (1.59%) |
| Kidney failure | 58 (3.41%) |
| Autoimmune disease | 62 (3.64%) |
| Thyroid disease | 117 (6.88%) |
| COPD | 74 (4.35%) |
| Liver cirrhosis | 25 (1.47%) |
| HBV | 28 (1.65%) |
| HCV | 89 (5.23%) |
| HIV | 3 (0.18%) |
| Smoke | 505 (29.69%) |
| Antiplatelet therapy | 308 (18.11%) |
| Anticoagulant therapy | 134 (7.88%) |
| Steroids | 29 (1.70%) |
| Intravenous Bisphosphonates | 4 (0.24%) |
| Oral Bisphosphonates | 37 (2.18%) |
| Immunosuppressive therapy | 24 (1.41%) |
| Colchicine | 1 (0.06%) |
| Chemotherapy | 2 (0.12%) |
| Head and neck radiotherapy | 15 (0.88%) |
| Polypharmacological treatment | 975 (57.32%) |
COPD: chronic obstructive pulmonary disease; HBV: Hepatitis B virus-infection; HCV: Hepatitis C virus-infection; HIV: HIV-infection.